Quick Summary
This study looked at whether three common viruses—Epstein-Barr virus (EBV), human herpesvirus 6, and human herpesvirus 7—might be linked to ME/CFS. Researchers compared blood samples from ME/CFS patients (some whose illness started with mono-like symptoms and some whose didn't) with healthy people. They found that ME/CFS patients had higher levels of antibodies to all three viruses, suggesting these viruses might reactivate in people with ME/CFS.
Why It Matters
This study contributes to understanding whether dormant herpes family viruses reactivate in ME/CFS, which could explain symptom patterns and inform future treatment strategies. Finding objective biological markers like elevated viral antibodies helps validate ME/CFS as a physical illness and provides direction for mechanistic research.
Observed Findings
What the study reports it measured.
- High EBV antibody titers were demonstrated in most ME/CFS patients
- EBV ZEBRA antibodies were detected at higher frequency in CFS patients than in healthy controls
- HHV-6 antibody titers were higher in CFS patients than in controls
- HHV-7 antibody titers were higher in CFS patients than in controls
- No significant difference in antibody patterns was observed between CIM and non-CIM patient subgroups
Inferred Conclusions
What the authors interpret from those results.
- ME/CFS patients may experience reactivation of EBV, HHV-6, and HHV-7
- Viral reactivation markers are more common in ME/CFS than in the healthy population
- Multiple herpes family viruses may be simultaneously involved in ME/CFS pathophysiology
Remaining Questions
- Does viral reactivation cause ME/CFS symptoms, or is it a consequence of immune dysregulation?
- What triggers reactivation of these viruses in ME/CFS patients specifically?
- Are the elevated antibody titers associated with symptom severity or specific symptom clusters?
- Do antiviral treatments targeting these viruses improve ME/CFS outcomes?
What This Study Does Not Prove
This study does not prove that these viruses cause ME/CFS—elevated antibodies may be a consequence rather than a cause of the illness. It also does not establish whether viral reactivation is a primary driver of disease or a secondary effect of immune dysfunction in ME/CFS patients.
Explore further
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Cite this study
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Sairenji, T, Yamanishi, K, Tachibana, Y, Bertoni, G, & Kurata, T (1995). Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.. Intervirology. https://doi.org/10.1159/000150450
BibTeX
@article{mecfsatlas-sairenji-1995-antibody-responses,
author = {Sairenji, T and Yamanishi, K and Tachibana, Y and Bertoni, G and Kurata, T},
title = {Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.},
journal = {Intervirology},
year = {1995},
doi = {10.1159/000150450},
note = {PubMed: 8724857},
url = {https://www.mecfsatlas.com/evidence/sairenji-1995-antibody-responses},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-11-13. https://www.mecfsatlas.com/evidence/sairenji-1995-antibody-responses
Contribute
Private, reviewed by a human. Not a public comment thread.